Why are there no clinically-approved drugs targeting disordered proteins?
Open Access
- 2 March 2026
- journal article
- review article
- Published by Elsevier in Current Opinion in Structural Biology
- Vol. 97, 103236
Abstract
No abstract availableKeywords
Funding Information
- Government of the United Kingdom
- Biotechnology and Biological Sciences Research Council (BB/X009955/1)
- Department for Science, Innovation and Technology
This publication has 76 references indexed in Scilit:
- AFflecto: A web server to generate conformational ensembles of flexible proteins from AlphaFold modelsJournal of Molecular Biology, 2025
- Cryo-Electron Tomography of Reconstituted Biomolecular Condensates2022
- Small Molecule Sequestration of the Intrinsically Disordered Protein, p27Kip1, Within Soluble OligomersJournal of Molecular Biology, 2021
- Intrinsically disordered proteins and biomolecular condensates as drug targetsCurrent Opinion in Chemical Biology, 2021
- Discovery of a Functional Covalent Ligand Targeting an Intrinsically Disordered Cysteine within MYCCell Chemical Biology, 2020
- Integrating Molecular Simulation and Experimental Data: A Bayesian/Maximum Entropy Reweighting Approach2020
- Sequence Specificity in the Entropy-Driven Binding of a Small Molecule and a Disordered PeptideJournal of Molecular Biology, 2017
- Hydrogen-exchange mass spectrometry for the study of intrinsic disorder in proteinsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2013
- Intrinsically disordered proteins are potential drug targetsCurrent Opinion in Chemical Biology, 2010
- Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen ReceptorCancer Cell, 2010